Yali Ding
Pennsylvania State University(US)Nanjing University of Chinese Medicine(CN)Chinese Center For Disease Control and Prevention(CN)Northwest University(CN)Dongguan People’s Hospital(CN)China Academy of Chinese Medical Sciences(CN)Children's Center(US)Penn State Milton S. Hershey Medical Center(US)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Childhood Cancer Survivors' Quality of Life, Biochemical and Molecular Research
Most-Cited Works
- → Dose-effect relationship and molecular mechanism by which BMSC-derived exosomes promote peripheral nerve regeneration after crush injury(2020)102 cited
- → Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia(2015)96 cited
- → IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia(2020)70 cited
- → Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia(2015)58 cited
- → Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia(2015)56 cited
- → Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies(2016)55 cited